Background: Neonatal pneumothorax (PTX) can occur due to underlying pulmonary disease and/or ventilatory support. PTX can also develop at the onset of respiration. PTX can be life-threatening, and prompt diagnosis is essential to reduce mortality. Objective: To analyse aetiology, demographic aspects, age at diagnosis, required treatment (specifically drainage), and prognosis of all cases of neonatal PTX observed in the North Jutland Region of Denmark from 1 January 2006 to 31 December 2014. Method: Retrospective, descriptive, population-based cohort study. Results: During the study period there were 48,968 live births and 71 cases of PTX, giving an incidence of PTX of 0.14% (95% Cl: 0.11-0.18). Of these, 21% were bilateral and 59% tension PTX. Fifty-two percent of neonates affected were born at term. Almost all neonates had underlying lung disease, most commonly transient tachypnea of the newborn (TTN) in 39% and respiratory distress syndrome (RDS) in 42%. Only 3% were considered to have developed PTX at the onset of respiration. In preterm neonates, the median age at diagnosis was 28.5 h (IQR: 18.3-48.6), whereas in infants born at term the median age was 6.1 h (IQR: 1.1-17.2) (p < 0.001). Thirteen percent of PTX infants died. Fifty-nine percent of the infants required drainage of the PTX, more frequently those with RDS than TTN. Conclusion: Almost all infants with PTX had underlying lung disease, divided equally between RDS and TTN. The diagnosis of PTX was made earlier in infants with TTN than RDS. Neonates with RDS required drainage more often than those with TTN.

Keywords:
Neonatal pneumothorax, Respiratory distress syndrome, Transient tachypnea of the newborn, Chest drain, needle aspiration
1.
Trevisanuto D, Doglioni N, Ferrarese P, Vedovato S, Cosmi E, Zanardo V: Neonatal pneumothorax: comparison between neonatal transfers and inborn infants. J Perinat Med 2005;33:449-454.
2.
Smith J, Schumacher RE, Donn SM, Sarkar S: Clinical course of symptomatic spontaneous pneumothorax in term and late preterm newborns: report from a large cohort. Am J Perinatol 2011;28:163-168.
3.
Dani C, Reali MF, Bertini G, Wiechmann L, Spagnolo A, Tangucci M, et al: Risk factors for the development of respiratory distress syndrome and transient tachypnoea in newborn infants. Eur Respir J 1999;14:155-159.
4.
Navaei F, Aliabadi B: Predisposing factors, incidence and mortality of pneumothorax in a neonatal intensive care unit in Isfahan, Iran. Chin J Contemp Pediatr 2010;12:417-420.
5.
Katar S, Devecioğlu C, Kervancioğlu M, Ulkü R: Symptomatic spontaneous pneumothorax in term newborns. Pediatr Surg Int 2006;22:755-758.
6.
Esme H, Doğru O, Eren S, Korkmaz M, Solak O: The factors affecting persistent pneumothorax and mortality in neonatal pneumothorax. Turk J Pediatr 2008;50:242-246.
7.
Ilçe Z, Gündogdu G, Kara C, Ilikkan B, Celayir S: Which patients are at risk? Evaluation of the morbility and mortality in newborn pneumothorax. Indian Pediatr 2003;40:325-328.
8.
Benterud T, Sandvik L, Lindemann R: Cesarean section is associated with more frequent pneumothorax and respiratory problems in the neonate. Acta Obstet Gynecol Scand 2009;88:359-361.
9.
Tudehop DI, Smyth MH: Is ‘transient tachypnoea of the newborn' always a benign disease? Aust Paediatr J 1979;15:160-165.
10.
Reynolds EO: Hyaline membrane disease. Am J Obs Gynecol 1970;106:780-794.
11.
Ainsworth AP, Ruager AR, Holtved E: Neonatal pneumothorax. Ugeskr Laeger 2000;162:6679-6682.
12.
Bhatia J, Mathew O: Resolution of pneumothorax in neonates. Crit Care Med 1985;13:417-419.
13.
Jones RM, Rutter N, Cooper AC, Pullan CR: Pneomothorax in the neonatal period. Anaesthesia 1983;38:948-952.
14.
Hibbard JU, Wilkins I, Sun L, Gregory K, Haberman S, Hoffman M, et al: Respiratory morbidity in late preterm births. JAMA 2010;304:419-425.
15.
Bhatia R, Davis PG, Doyle LW, Wong C, Morley CJ: Identification of pneumothorax in very preterm infants. J Pediatr 2011;159:115-120.e1.
16.
Aly H, Massaro A, Acun C, Ozen M: Pneumothorax in the newborn: clinical presentation, risk factors and outcomes. J Matern Fetal Neonatal Med 2014;27:402-406.
17.
Klinger G, Ish-Hurwitz S: Risk factors for pneumothorax in very low birth weight infants. Pediatr Crit Care Med 2008;9:398-402.
18.
Horbar J, Badger G, Carpenter J: Trends in mortality and morbidity for very low birth weight infants, 1991-1999. Pediatrics 2002;110:143-151.
19.
Litmanovitz I, Carlo W: Expectant management of pneumothorax in ventilated neonates. Pediatrics 2008;122:975-979.
20.
Kolås T, Saugstad OD, Daltveit AK, Nilsen ST, Øian P: Planned cesarean versus planned vaginal delivery at term: comparison of newborn infant outcomes. Am J Obstet Gynecol 2006;195:1538-1543.
21.
Zanardo V, Simbi AK, Franzio M, Solda G, Salvadori A, Trevisanuto D: Neonatal respiratory morbidity risk and mode of delivery at term: influence of timing of elective caesarian delivery. Acta Paediatr 2004;93:643-647.
22.
Wax JR, Herson V, Carignan E, Mather J, Ingardia CJ: Contribution of elective delivery to severe respiratory distress at term. Am J Perinatol 2002;19:81-86.
23.
Steele R V, Metz JR, Bass JW, DuBois JJ: Pneumothorax and pneumomediastinum in the newborn. Radiology 1971;98:629-632.
24.
Keszler M, Carbone MT, Cox C, Schumacher RE: Severe respiratory failure after elective repeat cesarean delivery: a potentially preventable condition leading to extracorporeal membrane oxygenation. Pediatrics 1992;89:670-672.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.